You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ETHYOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ethyol patents expire, and what generic alternatives are available?

Ethyol is a drug marketed by Clinigen and is included in one NDA.

The generic ingredient in ETHYOL is amifostine. There are six drug master file entries for this compound. Additional details are available on the amifostine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ETHYOL?
  • What are the global sales for ETHYOL?
  • What is Average Wholesale Price for ETHYOL?
Summary for ETHYOL
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 98
Clinical Trials: 32
Patent Applications: 5,235
Drug Prices: Drug price information for ETHYOL
What excipients (inactive ingredients) are in ETHYOL?ETHYOL excipients list
DailyMed Link:ETHYOL at DailyMed
Drug patent expirations by year for ETHYOL
Drug Prices for ETHYOL

See drug prices for ETHYOL

Recent Clinical Trials for ETHYOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
M.D. Anderson Cancer CenterPhase 1
Children's Hospital Medical Center, CincinnatiPhase 2
AstraZenecaPhase 2

See all ETHYOL clinical trials

Paragraph IV (Patent) Challenges for ETHYOL
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ETHYOL For Injection amifostine 500 mg/vial 020221 1 2004-04-16

US Patents and Regulatory Information for ETHYOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ETHYOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ⤷  Sign Up ⤷  Sign Up
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ⤷  Sign Up ⤷  Sign Up
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ⤷  Sign Up ⤷  Sign Up
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 ⤷  Sign Up ⤷  Sign Up
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-002 Sep 10, 1999 ⤷  Sign Up ⤷  Sign Up
Clinigen ETHYOL amifostine INJECTABLE;INJECTION 020221-001 Dec 8, 1995 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.